Whole-exome sequencing of their tumor tissues obtained at baseline and after disease progression revealed over 90% truncating dysfunctional mutations in both JAK1 (Q503* nonsense mutation) and JAK2 (F547 splice-site mutation). The gene discussed is JAK1; the disease is neoplasm.